Hoffmann-La Roche [clinicaltrials_resource:d7dd5d3cc8c5f417e9358ed7f969097c]
Clinical Trials [clinicaltrials_resource:01112054a8e19feb83afc0f8124e4772]Clinical Trials [clinicaltrials_resource:019b52f69588246440ea57a97cacfa07]Jean Ayache, M.D. [clinicaltrials_resource:01d4e28b7d569f4408752313589722e2]Clinical Trials [clinicaltrials_resource:02eef706ecd46a74dd91f20ab4133b44]Clinical Trials [clinicaltrials_resource:06a7e4fb7f5da8a939ce45bee84aba2c]Clinical Trials [clinicaltrials_resource:06c9a99337d8dc580b12316532a2cad9]Clinical Trials [clinicaltrials_resource:083e1b7ed2007d91fd8472ad1d743aa9]Clinical Trials [clinicaltrials_resource:0a6de54aa2c7aee3299bcd281e5a80c0]Clinical Trials [clinicaltrials_resource:0b25763c2e53a4e09d41abf439603677]Clinical Trials [clinicaltrials_resource:0d726422035ee9fdb8921d8043bf47de]Clinical Trials [clinicaltrials_resource:0dea092cbc7d634ac4ebf9617146f41e]Clinical Trials [clinicaltrials_resource:0e24952a8f809f98bfccea01a8514679]Clinical Trials [clinicaltrials_resource:103035a4ce28d98e1f823e35eca7c2ae]Clinical Trials [clinicaltrials_resource:10eccb9a5f8dc8279fd1acf5ee50ca48]Clinical Trials [clinicaltrials_resource:11250ef24fbbfcc1605e402bd028a8eb]Clinical Trials [clinicaltrials_resource:1143465583ff4a958e9eb93d12870cbd]Clinical Trials [clinicaltrials_resource:121669f5f551ebe6792c607c85e3bf2e]Clinical Trials [clinicaltrials_resource:1579b4b91b135bb42c206828d2990abb]Clinical Trials [clinicaltrials_resource:15ff545c7d9ec3f66b9a5427f648ff2f]Clinical Trials [clinicaltrials_resource:16637f794c3e76bfd0ea0a16a2c1f6fb]Clinical Trials [clinicaltrials_resource:16c6bfe8a81b9a48f0eb2b738d21e23f]Clinical Trials [clinicaltrials_resource:16e0f258682afcc81725279cb65c1bcc]Clinical Trials [clinicaltrials_resource:1a08d7d8bde2d3a8177f96655823b39c]Clinical Trials [clinicaltrials_resource:1ac705b78b658d01f863b3ca8141af96]Clinical Trials [clinicaltrials_resource:1b0f69884227c210bb5f19ccda310ca5]Clinical Trials [clinicaltrials_resource:1c0cffd9a68c699167bb1a81019dac2a]Clinical Trials [clinicaltrials_resource:1cc6fdb9563050d6c54ef6ab78194f1e]Clinical Trials [clinicaltrials_resource:1f2a758de4ecf256540d92d02e326d03]Clinical Trials [clinicaltrials_resource:201465e0ae61f46cfc3bddc6f8520360]Clinical Trials [clinicaltrials_resource:20b40c628217e863e212a35bd77173a8]Clinical Trials [clinicaltrials_resource:2358daeacece67deecb452da20042ca2]Clinical Trials [clinicaltrials_resource:25a2dd031c725fb64561c59692e584bf]Clinical Trials [clinicaltrials_resource:2785fd801f7b392a081edbf98ae07777]Clinical Trials [clinicaltrials_resource:27bad782726bb51ff948d3e9c3faaeb8]Clinical Trials [clinicaltrials_resource:286c2e7c08c56139eb99d073362f36d7]Clinical Trials [clinicaltrials_resource:28f8aa89f551c9e0cc12fdac7194ae63]Clinical Trials [clinicaltrials_resource:2b2f2a6d6b8f8ae8ba77df6f20787b19]Clinical Trials [clinicaltrials_resource:2e6e74258064c186a5d33005322fb228]Clinical Trials [clinicaltrials_resource:2f3a8cac4f858e720b0280290b672c23]Clinical Trials [clinicaltrials_resource:31a77331ddbf9580314964599b524e40]
affiliation [clinicaltrials_vocabulary:affiliation]
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [clinicaltrials:NCT00002239]T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs [clinicaltrials:NCT00008528]T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs [clinicaltrials:NCT00021554]clinicaltrials:NCT00022672T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents [clinicaltrials:NCT00022763]clinicaltrials:NCT00045032A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients [clinicaltrials:NCT00089492]clinicaltrials:NCT00090051clinicaltrials:NCT00112918WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV. [clinicaltrials:NCT00233883]clinicaltrials:NCT00281918BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. [clinicaltrials:NCT00326963]BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection [clinicaltrials:NCT00337701]clinicaltrials:NCT00377637clinicaltrials:NCT00397839A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis. [clinicaltrials:NCT00408213]Safety and Efficacy Study of Re-treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies [clinicaltrials:NCT00468377]A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy [clinicaltrials:NCT00468546]clinicaltrials:NCT00486759clinicaltrials:NCT00488059A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. [clinicaltrials:NCT00545051]SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. [clinicaltrials:NCT00545480]A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. [clinicaltrials:NCT00577109]A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. [clinicaltrials:NCT00642941]clinicaltrials:NCT00683930A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis [clinicaltrials:NCT00683969]clinicaltrials:NCT00711191A Study of Avastin (Bevacizumab) in Combination With Neoadjuvant Treatment Regimens in Patients With Primary HER2 Negative Breast Cancer [clinicaltrials:NCT00773695]clinicaltrials:NCT00875979clinicaltrials:NCT01010061clinicaltrials:NCT01041404A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive [clinicaltrials:NCT01086085]clinicaltrials:NCT01118377A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE) [clinicaltrials:NCT01120184]A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS [clinicaltrials:NCT01149057]A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Patients With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy [clinicaltrials:NCT01174563]A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) [clinicaltrials:NCT01287741]A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With MabThera/Rituxan (Rituximab) Plus Chemotherapy Followed by GA101 or MabThera/Rituxan Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) [clinicaltrials:NCT01332968]An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer [clinicaltrials:NCT01339832]A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer [clinicaltrials:NCT01358877]
collaborator [clinicaltrials_vocabulary:collaborator]
Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [clinicaltrials:NCT00001040]Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections [clinicaltrials:NCT00002024]Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient [clinicaltrials:NCT00002025]A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS [clinicaltrials:NCT00002034]Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease [clinicaltrials:NCT00002081]A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus [clinicaltrials:NCT00002095]A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine [clinicaltrials:NCT00002096]A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection [clinicaltrials:NCT00002117]An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies [clinicaltrials:NCT00002118]An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access [clinicaltrials:NCT00002135]Treatment of Psoriasis Using Acitretin in HIV-Positive Patients [clinicaltrials:NCT00002143]A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs [clinicaltrials:NCT00002162]A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients [clinicaltrials:NCT00002178]A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients [clinicaltrials:NCT00002190]A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS [clinicaltrials:NCT00002222]Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients [clinicaltrials:NCT00002229]A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [clinicaltrials:NCT00002239]A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy [clinicaltrials:NCT00002247]A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir [clinicaltrials:NCT00002251]Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy. [clinicaltrials:NCT00002256]A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS [clinicaltrials:NCT00002257]An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492 [clinicaltrials:NCT00002265]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS [clinicaltrials:NCT00002273]A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT) [clinicaltrials:NCT00002279]The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [clinicaltrials:NCT00002299]A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma [clinicaltrials:NCT00002314]A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine [clinicaltrials:NCT00002333]A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment [clinicaltrials:NCT00002334]A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002367]A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients [clinicaltrials:NCT00002374]A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes [clinicaltrials:NCT00002377]A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients [clinicaltrials:NCT00002378]The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children [clinicaltrials:NCT00002380]A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients [clinicaltrials:NCT00002382]A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients [clinicaltrials:NCT00002383]A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease [clinicaltrials:NCT00002397]The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs [clinicaltrials:NCT00002425]A Study to Compare Two Anti-HIV Drug Combinations [clinicaltrials:NCT00002447]A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients [clinicaltrials:NCT00002448]Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00005649]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [clinicaltrials:NCT00002239]A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes [clinicaltrials:NCT00002377]A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer [clinicaltrials:NCT00009737]clinicaltrials:NCT00022672T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents [clinicaltrials:NCT00022763]clinicaltrials:NCT00045032Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids [clinicaltrials:NCT00048009]Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma [clinicaltrials:NCT00048022]A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [clinicaltrials:NCT00048035]A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. [clinicaltrials:NCT00048048]MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis [clinicaltrials:NCT00048061]DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis [clinicaltrials:NCT00048074]A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [clinicaltrials:NCT00048126]A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [clinicaltrials:NCT00048139]A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [clinicaltrials:NCT00048152]Efficacy Study of Zenapax in Combination With CellCept, Cyclosporine and Corticosteroids in Heart Transplant [clinicaltrials:NCT00048165]Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B [clinicaltrials:NCT00048945]Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus [clinicaltrials:NCT00057304]Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus [clinicaltrials:NCT00057317]A Study of Capecitabine (Xeloda) as a First-line Therapy in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00069095]A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00069108]clinicaltrials:NCT00069121A Study of Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077597]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077610]A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077623]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077766]clinicaltrials:NCT00077857A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [clinicaltrials:NCT00081471]A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00081484]clinicaltrials:NCT00081653A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation [clinicaltrials:NCT00087581]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]A Study of Capecitabine In Combination With Docetaxel Vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer [clinicaltrials:NCT00087620]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]clinicaltrials:NCT00089479
source [clinicaltrials_vocabulary:source]
Hoffmann-La Roche [clinicaltrials_resource:d7dd5d3cc8c5f417e9358ed7f969097c]
Bio2RDF identifier
d7dd5d3cc8c5f417e9358ed7f969097c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d7dd5d3cc8c5f417e9358ed7f969097c
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:d7dd5d3cc8c5f417e9358ed7f969097c
title
Hoffmann-La Roche
@en
type
label
Hoffmann-La Roche [clinicaltrials_resource:d7dd5d3cc8c5f417e9358ed7f969097c]
@en